Posts by CT Team

Budget 2018 tax update – Confluence Tax

On October 30th Confluence Tax held a post-budget briefing to update clients on the tax implications of the Chancellor’s 2018 pre-Brexit budget.  Here is the slide deck of the presentation. Feel free to download it and do get in touch if you have any questions. Read more about UK R&D Tax Credits. View the presentation…

Read More

2018 budget: a tax update for biotech and tech businesses

Downing Street road sign

  Invitation to the essential 2018 post-budget briefing and general tax update for biotech and tech companies a free event We’ll keep it brief as you’re all busy but we’ll distill the significant bits of Chancellor Philip Hammond’s budget and discuss how they relate to biotech and tech businesses. The Confluence Tax team will be…

Read More

Enterprise Management Incentives (EMI) share options guide

Questions to ask for an EMI scheme

  Enterprise Management Incentives (EMI) share options guide COMPANIES in the biotech and tech spaces have a constant need to incentivise staff and build motivated teams to prepare them down the line for a sale or investment. Part of that process should include consideration of equity incentives and the tax implications of granting these share…

Read More

Rise and fall of film partnerships

Hollywood sign USA

A tax perspective Tax is our world. We live and breathe it and always find the most tax-efficient – and legal – solutions for our clients, that’s a given. Film partnerships do not generally figure in the tech and biotech niche we inhabit, but they’ve caught our attention in the press recently, so here’s our…

Read More

F-Star collaboration

As announced today (May 31), Confluence Tax is delighted to have assisted F-star on the acquisition of the asset-centric vehicle F-Star Gamma by Denali Therapeutics, leveraging F-star’s Modular Antibody Technology™ beyond immuno-oncology. Read the full press release here. 

Read More